About U2medtek
U2medtek is a company based in Ulsan (South Korea) founded in 2017. U2medtek offers products and services including Health Insight and U2vital. U2medtek operates in a competitive market with competitors including Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and Synergia Medical, among others.
- Headquarter Ulsan, South Korea
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website u2medtek.com
- Legal Name Youto Medech Co., Ltd.
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of U2medtek
U2medtek operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of U2medtek
U2medtek offers a comprehensive portfolio of products and services, including Health Insight and U2vital.
Program for monitoring blood sugar and providing personalized coaching
AI solution for analyzing health check results and measuring health age
People of U2medtek
1 people are tracked at U2medtek (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kim Yang Seok | CEO | Leadership |
Complete people profiles for U2medtek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of U2medtek
U2medtek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and Synergia Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| nexstim.com | 2000 | Helsinki, Finland | $29.67M | – | Noninvasive brain stimulation is provided for stroke patient rehabilitation. | |
| mindmaze.com | 2012 | Lausanne, Switzerland | $223.5M | – | Evidence-based digital neurotherapeutics are developed for brain health recovery. | |
| precisionneuro.io | 2021 | New York, United States | $182.65M | 22 | Brain-computer interfaces developed for medical treatment and drug development. | |
| synergia-medical.com | 2013 | Mont Saint Guibert, Belgium | $14.16M | 18 | Implantable neurostimulators and contactless monitoring systems are developed. | |
| endonovo.com | 2011 | Los Angeles, United States | – | – | Bioelectronic devices are developed for regenerative medicine therapies. | |
| minnetronixmedical.com | 1996 | Saint Paul, United States | $20M | 263 | Multiple devices for neurocritical patients are manufactured and developed. | |
| heliusmedical.com | 2014 | Newtown Square, United States | $391,092 | 26 | Neurological rehabilitation devices are developed for brain healing amplification. | |
| gtec.at | 1999 | Schiedlberg, Austria | – | – | Provider of high-performance brain-computer interfaces and neurotechnologies for invasive and non-invasive recordings |
Detailed competitors of U2medtek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to U2medtek
10 companies that operate in the same segment as U2medtek (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about U2medtek
U2medtek was founded in 2017.
U2medtek is headquartered in Ulsan, South Korea.
Kim Yang Seok is the current CEO of U2medtek.
U2medtek was founded in 2017 in Ulsan, South Korea, as a manufacturer of specialized medical devices. Focus is placed on equipment for sinus imaging, parathyroid diagnosis, and optical systems for conditions like maxillary sinusitis. Patents are held for various devices, including a mouthpiece designed for sinusitis measurement. Operations center on producing diagnostic tools for healthcare applications in the medical technology sector.
U2medtek's top competitors include Blackrock Neurotech, Precision Neuroscience and Nexstim.
U2medtek offers Health Insight and U2vital.
U2medtek operates through ,.